Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Addex Therapeutics Ltd    ADXN   CH0029850754

 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
02/21/2017 02/22/2017 02/23/2017 02/24/2017 02/27/2017 Date
2.25(c) 2.21(c) 2.15(c) 2.12(c) 2.32 Last
17 306 12 092 26 435 14 090 1 318 927 Volume
+2.27% -1.78% -2.71% -1.40% +9.43% Change
More quotes
Company
Addex Therapeutics Ltd. engages in the discovery and development of oral small molecule drugs.The company was founded by Vincent Mutel, Timothy Dyer and Mark Epping-Jordan in May 2002 and is headquartered in Geneva, Switzerland. 
More about the company
Latest news on ADDEX THERAPEUTICS LTD
07:03a ADDEX THERAPEUTICS : ADX71149 Anti-Epileptic Effect Highlighted in Scientific Jo..
07:01a ADDEX THERAPEUTICS : ADX71149 Anti-Epileptic Effect Highlighted in Scientific Jo..
02/06 ADDEX THERAPEUTICS : Clinical Programs and Discovery Platform Highlighted in Rev..
02/06 ADDEX THERAPEUTICS : Clinical Programs and Discovery Platform Highlighted in Rev..
02/01 ADDEX THERAPEUTICS : Awarded $835,000 Grant from Michael J. Fox Foundation to Ad..
01/31 ADDEX THERAPEUTICS : Awarded $835,000 Grant from Michael J. Fox Foundation to Ad..
01/31 ADDEX THERAPEUTICS : Awarded $835,000 Grant from Michael J. Fox Foundation to Ad..
01/10 ADDEX THERAPEUTICS : ADX71441 Demonstrates Statistically Significant Efficacy in..
01/09 ADDEX THERAPEUTICS : ADX71441 Demonstrates Statistically Significant Efficacy in..
2016 ADDEX THERAPEUTICS : ADX71441 Pharmacological Profile Published in Neuropharmaco..
More news
Sector news : Biotechnology & Medical Research - NEC
08:06aDJSANOFI : Lonza to Invest CHF290 Million in New Plant in Switzerland
02/22 Genmab and J&J's cancer drug set for blockbuster sales this year
02/21 Icahn buys Bristol-Myers shares, adding to activist pressure
02/21DJBristol-Myers Expands Board, Boosts Buybacks Amid Activist Pressure
02/16 How Sanofi lost out to J&J in $30 billion battle for Actelion
More sector news : Biotechnology & Medical Research - NEC
Latest Tweets
2016Addex Therapeutics : ADX71441 Pharmacological Profile Published in Neuropharm.. 
2016Addex Therapeutics Biopharmaceutical Industry Veteran, As Chief Medical Offic.. 
2016Addex Therapeutics : Appoints Biopharmaceutical Industry Veteran, Roger G. Mi.. 
2016Addex Therapeutics : to Conduct Phase IIa Proof of Concept Study of Dipraglur.. 
2016Addex Therapeutics : Reports First Half 2016 Operating Highlights and Financi.. 
More tweets
Qtime:3
Advertisement
Chart ADDEX THERAPEUTICS LTD
Duration : Period :
Addex Therapeutics Ltd Technical Analysis Chart | ADXN | CH0029850754 | 4-Traders
Full-screen chart
Technical analysis trends ADDEX THERAPEUTIC...
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
Managers
NameTitle
Timothy Dyer Chief Executive Officer
Vincent M. Lawton Chairman
Sonia Maria Poli Chief Scientific Officer
Roger G. Mills Chief Medical Officer
Raymond George Hill Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ADDEX THERAPEUTICS LTD16.85%28
INCYTE CORPORATION30.86%24 852
QUINTILES IMS HOLDINGS..2.09%18 301
CELLTRION, INC.--.--%10 911
LONZA GROUP AG2.04%10 319
SEATTLE GENETICS, INC.18.87%8 939
More Results